The JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) will jointly organise a webinar on the new recommendation on non-animal-derived antibodies.
The Recommendation states that animals should no longer be used for the development and production of antibodies for research, regulatory, diagnostic and therapeutic applications. It also challenges misconceptions existing in the scientific community about non-animal-derived antibodies and highlights the scientific and economic benefits of their use.
16 September, 16:00 CEST | Webinar ‘Scientific and economic benefits of animal-free antibodies’
We invite you to attend this webinar where:
- JRC scientist Joao Barroso will present a summary of the findings from the ESAC Opinion on the validity and benefits of using animal-free technology to produce affinity reagents and the subsequent EURL ECVAM Recommendation.
- ESAC member Alison Gray will provide an overview of the scientific benefits of using animal friendly affinity reagents as replacements for animal-derived antibodies.
To attend the webinar, register here
This event is taking place in the context of a webinar series on applications and benefits of animal-free recombinant antibodies. It is co-organised by the Joint Research Centre (JRC), the US National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and the PETA International Science Consortium Ltd.
More details and the list of all webinars are available here
From the European Commission’s Science and Knowledge Service: EU Science Hub, https://ec.europa.eu/jrc/en/event/webinar/webinar-animal-free-antibodies